BetaEntity Annotation Prototype
← Back to diseases

Annotated abstract

Sixty seconds on . . . pollen immunotherapy

bmj · 2025-08-04 · canonical JSON source

7 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

The National Institute for Health and Care Excellence (NICE) has recommended betula verrucos (Itulazax), a once daily immunotherapy tablet for people with moderate to severe allergic rhinitis or conjunctivitis (hay fever) caused by birch tree pollen.